Daily Stock Analysis, APHB, AmpliPhi Biosciences Corp, priceseries

AmpliPhi Biosciences Corp. Daily Stock Analysis
Stock Information
Open
0.00
Close
0.00
High
0.00
Low
0.00
Previous Close
0.00
Daily Price Gain
0.00
YTD High
0.00
YTD High Date
Wrong Month 0, 0
YTD Low
0.00
YTD Low Date
Wrong Month 0, 0
YTD Price Change
0.00
YTD Gain
-nan%
52 Week High
0.00
52 Week High Date
Wrong Month 0, 0
52 Week Low
0.00
52 Week Low Date
Wrong Month 0, 0
52 Week Price Change
0.00
52 Week Gain
-nan%
Company Information
Stock Symbol
APHB
Exchange
NYSE MKT
Company URL
http://www.ampliphibio.com
Company Phone
804-827-2524
CEO
M. Scott Salka
Headquarters
California
Business Address
3579 VALLEY CENTRE DRIVE, SAN DIEGO, CA 92130
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0000921114
About

AmpliPhi Biosciences Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel phage therapeutics. It operates in segments of the biotechnology and biopharmaceutical markets. The company was founded in March 1989 and is headquartered in San Diego, CA.

Description

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the discovery, development, and commercialization of various bacteriophage therapeutics. Its lead product candidate comprises AB-SA01 that is in Phase I clinical trial for the treatment of Staphylococcus aureus (S. aureus) infections, including methicillin-resistant S. aureus. The company's products under development include AB-PA01 for the treatment of Pseudomonas aeruginosa lung infections in cystic fibrosis patients; and AB-CD01 for the treatment of Clostridium difficile infections. It has a collaboration agreement with Intrexon Corporation to utilize synthetic biology platform for the identification, development, and production of bacteriophage-containing human therapeutics. The company was formerly known as Targeted Genetics Corporation and changed its name to AmpliPhi Biosciences Corporation in February 2011. AmpliPhi Biosciences Corporation was founded in 1989 and is based in San Diego, California.